Categories
-
Adhesives
5
Amines
91
Amino Acids
179
Analytical Reagents
668
Antibiotics
246
Bioactive Small Molecules
715
Aroma Chemicals
203
Biochemicals
1003
Boronic Acids
4
Buffers
96
Building Blocks
1759
Carbohydrates
176
Catalysts
96
Chiral Compounds
53
Coccus nucifera oil
0
Detergents
57
Diagnostic Raw Materials
257
Flavours and Fragrance Materials
202
Fluorinated Products
43
Furans
5
Gases in Solution
47
Grignard Reagents
18
HPLC Reagents
8
Imidazoles
17
Indoles
41
Inorganic Chemicals
321
Ion-Pair Reagents
24
Ligands
79
Organics
1295
Oxazoles
3
Peptide Reagents
89
Phenols
45
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
42
Reagents
97
Research Organics & Inorganics
752
Salts
281
Sealing Compounds
1
Sherclin
1
Solvents
121
Stains & Indicators
292
Sugars
63
Tailor-made solutions
1
Testing Standards
4
Uncategorised
89
Water Analysis
12
L-Ascorbic acid sodium salt
(30254296 | 134-03-2)
CAS: | 134-03-2 |
---|---|
Molecular Formula: | C6H7NaO6 |
Molecular Weight: | 198.11 |
Availablility: | In Stock |
---|---|
Downloads: | | |
30254296-100g | 100g | £30.90 | |
30254296-500g | 500g | £82.40 | |
Bulk Order |
30254296-100g | 100g | €43.30 | |
30254296-500g | 500g | €115.40 | |
Bulk Order |
30254296-100g | 100g | $46.40 | |
30254296-500g | 500g | $123.60 | |
Bulk Order |
Safety Data Sheet
Certificate of Analysis
Product Detail
Product Code | 30254296 | ||||
Product Name | L-Ascorbic acid sodium salt | ||||
Categories | Biochemicals Building Blocks | ||||
CAS | 134-03-2 | ||||
Molecular Formula | C6H7NaO6 | ||||
Molecular Weight | 198.11 | ||||
Storage Details | Ambient | ||||
Harmonised Tariff Code | 2936270000 |
Product Specification
Specific rotation | +103° to +108° | ||||
Lead | 10ppm max | ||||
pH | 7.0 - 8.0 | ||||
Loss on Drying | 0.25% max | ||||
Assay | 99% min | ||||
Appearance | White powder to light yellow crystalline powder | ||||
Heavy Metal | 20ppm max |
Safety Information
Pictograms |
|
||||
Signal word | none | ||||
Hazard statements |
|
||||
Precautionary statements |
|